Lorna McInroy
Director of Clinical Biomarkers Moderna
Experienced Research Development Project/facility Lead with a demonstrated history of working in the pharmaceuticals and medical device industry. Skilled in Good Laboratory Practice (GLP), Medical Devices, Vaccine development and Good Clinical Practice (GCP). Strong scientific professional with a PhD focused in Cell and molecular cancer Biology from Durham University.
Seminars
Tuesday 31st March 2026
Panel Discussion: Advancing Sample Management & Pre-Analytic Workflows for Robust, Reproducible Clinical Outcomes
4:50 pm
- What are the main challenges and hurdles considering clinical sample and biomarker strategies to reduce downstream risk?
- What innovations in digital tools are facilitating end-to-end integrity and reproducibility?
- How are sponsors ensuring consistency in biospecimen handling when working across multiple CROs or laboratory partners?
Wednesday 1st April 2026
Building Resilient Biomarker Infrastructure: From Pandemic Preparedness to Clinical Testing Excellence
3:10 pm
- Accelerating biomarker delivery through integrated assay platforms – how Moderna’s UK Clinical Biomarker Laboratory is enabling rapid, compliant deployment of immunoassay, cytometry, and molecular methods for global clinical programs
- Embedding automation and AI in sample and data workflows – leveraging robotic biobanking, and digital traceability to enhance efficiency, reproducibility, and data integrity
- Pandemic preparedness and translational resilience – establishing high-containment and rapid-assay transfer capabilities to respond to emerging pathogens and future public-health challenges
